Weekly Triple-Action Diabetes Injection Retatrutide Shows Major Weight Loss and Blood Sugar Reduction in Phase 3 Trials
A new weekly injectable drug, retatrutide, designed for type 2 diabetes, has shown striking results in phase 3 trials, significantly
Read More